PRRT2 and pancreatic neoplasm: The purpose of this research is to develop PKC inhibitor-anchored Gem Elaidate-loaded PEGylated nanoliposomes (PGPLs) and to investigate their anticancer activity in 2D and 3D models of pancreatic cancer.